DE69636013D1 - Verfahren zum erlangen von rezeptor-freigabeligand (reland)-komplexen und testansätze - Google Patents

Verfahren zum erlangen von rezeptor-freigabeligand (reland)-komplexen und testansätze

Info

Publication number
DE69636013D1
DE69636013D1 DE69636013T DE69636013T DE69636013D1 DE 69636013 D1 DE69636013 D1 DE 69636013D1 DE 69636013 T DE69636013 T DE 69636013T DE 69636013 T DE69636013 T DE 69636013T DE 69636013 D1 DE69636013 D1 DE 69636013D1
Authority
DE
Germany
Prior art keywords
reland
receptor
analyte
components
testing approaches
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69636013T
Other languages
English (en)
Other versions
DE69636013T2 (de
Inventor
Judith Fitzpatrick
Regina Lenda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Serex Inc
Original Assignee
Serex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serex Inc filed Critical Serex Inc
Application granted granted Critical
Publication of DE69636013D1 publication Critical patent/DE69636013D1/de
Publication of DE69636013T2 publication Critical patent/DE69636013T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DE69636013T 1995-06-22 1996-06-19 Verfahren zum erlangen von rezeptor-freigabeligand (reland)-komplexen und testansätze Expired - Fee Related DE69636013T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US493420 1995-06-22
US08/493,420 US5710009A (en) 1994-02-17 1995-06-22 Receptor:release ligand (reland) complexes and release assays using said reland and methods and kits based thereon
PCT/US1996/010566 WO1997001097A1 (en) 1995-06-22 1996-06-19 Receptor:release ligand (reland) complexes and assays and kits based thereon

Publications (2)

Publication Number Publication Date
DE69636013D1 true DE69636013D1 (de) 2006-05-18
DE69636013T2 DE69636013T2 (de) 2007-04-12

Family

ID=23960154

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69636013T Expired - Fee Related DE69636013T2 (de) 1995-06-22 1996-06-19 Verfahren zum erlangen von rezeptor-freigabeligand (reland)-komplexen und testansätze

Country Status (9)

Country Link
US (1) US5710009A (de)
EP (1) EP0840895B1 (de)
JP (1) JP3103379B2 (de)
AT (1) ATE322685T1 (de)
AU (1) AU6387596A (de)
CA (1) CA2225210C (de)
DE (1) DE69636013T2 (de)
ES (1) ES2265646T3 (de)
WO (1) WO1997001097A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01155293U (de) * 1988-04-15 1989-10-25
FI100276B (fi) * 1996-02-06 1997-10-31 Orion Yhtymae Oy Menetelmä analyyttien ei-kilpailevaa määritystä varten
US20020131972A1 (en) * 1998-05-21 2002-09-19 Daniel Sem Multi-partite ligands and methods of identifying and using same
DE69917258T2 (de) 1998-06-01 2005-07-14 Roche Diagnostics Corp., Indianapolis Methode und vorrichtung zum elektrochemischen immunoassay mehrerer analyten
US7166475B2 (en) * 1999-02-26 2007-01-23 Cyclacel Ltd. Compositions and methods for monitoring the modification state of a pair of polypeptides
JP2002539458A (ja) * 1999-03-16 2002-11-19 セレックス， インコーポレイテッド 唾液中のａｐｏａおよびａｐｏｂ、ならびにそれらの比を検出するための方法およびデバイス
US6699722B2 (en) 2000-04-14 2004-03-02 A-Fem Medical Corporation Positive detection lateral-flow apparatus and method for small and large analytes
EP1420641A4 (de) * 2001-08-01 2005-05-25 Anil K Chauhan Immunkomplexe
US7653490B2 (en) * 2001-09-10 2010-01-26 Triad Liquidating Company LLC Nuclear magnetic resonance assembly of chemical entities
US20030180797A1 (en) * 2002-03-20 2003-09-25 Lin Yu Identification of ligands for a receptor family and related methods
US20040208865A1 (en) * 2003-02-12 2004-10-21 Chauhan Anil K. Immune complexes
WO2010009459A1 (en) * 2008-07-18 2010-01-21 Bayer Healthcare Llc Methods, devices, and systems for glycated hemoglobin analysis
CN102126862B (zh) * 2010-01-12 2012-10-10 宝山钢铁股份有限公司 一种焦炉炭化室炉墙涂层材料及其使用方法
EP2686680B1 (de) * 2011-03-18 2018-06-13 Biotium Inc. Fluoreszierende farbstoffe, fluoreszenzfarbstoffkits und verfahren zur herstellung von markierter moleküle
US11422136B2 (en) * 2017-10-19 2022-08-23 Idexx Laboratories, Inc. Detection of symmetrical dimethylarginine

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817837A (en) * 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US4069105A (en) * 1977-03-03 1978-01-17 Syva Company Lidocaine antigens and antibodies
US4318707A (en) * 1978-11-24 1982-03-09 Syva Company Macromolecular fluorescent quencher particle in specific receptor assays
US4323507A (en) * 1979-02-12 1982-04-06 Syva Company Valproate conjugation using dicarbonyls
US4341866A (en) * 1980-06-02 1982-07-27 Syva Company Antienzyme termination in enzyme immunoassays
GB2078370A (en) * 1980-06-13 1982-01-06 Nat Res Dev Binding assays
US4590278A (en) * 1981-01-29 1986-05-20 Philip Morris Incorporated Nicotine analogs
US4533493A (en) * 1981-08-27 1985-08-06 Miles Laboratories, Inc. Theophylline immunogens, antibodies, labeled conjugates, and related derivatives
US4480042A (en) * 1981-10-28 1984-10-30 E. I. Du Pont De Nemours And Company Covalently bonded high refractive index particle reagents and their use in light scattering immunoassays
US4434236A (en) * 1982-10-20 1984-02-28 E. I. Du Pont De Nemours & Co. Immunoassay wherein labeled antibody is displaced from immobilized analyte-analogue
US4504412A (en) * 1983-02-07 1985-03-12 National Distillers And Chemical Corporation Cyclohexane derivatives in fragrance compositions
US4551426A (en) * 1983-10-03 1985-11-05 E. I. Du Pont De Nemours And Company Heterogeneous immunoassay for digoxin using ouabain as a separation means
US4766064A (en) * 1984-05-07 1988-08-23 Allied Corporation Displacement polynucleotide assay employing polyether and diagnostic kit
US4977077A (en) * 1984-10-24 1990-12-11 Bioprobe International Integrated solid-phase immunoassay
JPH0750114B2 (ja) * 1986-03-17 1995-05-31 富士写真フイルム株式会社 免疫分析器具を用いる分析方法
US5137808A (en) * 1987-04-07 1992-08-11 Syntex (U.S.A.) Inc. Immunoassay device
US5009998A (en) * 1987-06-26 1991-04-23 E. I. Du Pont De Nemours And Company Method for performing heterogeneous immunoassay
DE3922960A1 (de) * 1989-07-12 1991-01-17 Boehringer Mannheim Gmbh Verfahren zur bestimmung eines analyten
US5183740A (en) * 1990-02-23 1993-02-02 The United States Of America As Represented By The Secretary Of The Navy Flow immunosensor method and apparatus
US5164504A (en) * 1991-01-16 1992-11-17 Abbott Laboratories Haptens, tracers, immunogens and antibodies for immunoassays for cotinine derivatives
EP0600936B1 (de) * 1991-07-29 1999-10-06 Serex, Inc. Differentielle bindungsaffinitäten und darauf beruhende dissoziationstestverfahren
WO1995016026A1 (en) * 1993-12-10 1995-06-15 Abbott Laboratories Reagents and methods for the detection of methotrexate

Also Published As

Publication number Publication date
CA2225210C (en) 2004-02-17
JP3103379B2 (ja) 2000-10-30
EP0840895A1 (de) 1998-05-13
EP0840895A4 (de) 2000-04-26
ATE322685T1 (de) 2006-04-15
JPH10511776A (ja) 1998-11-10
US5710009A (en) 1998-01-20
AU6387596A (en) 1997-01-22
WO1997001097A1 (en) 1997-01-09
CA2225210A1 (en) 1997-01-09
DE69636013T2 (de) 2007-04-12
ES2265646T3 (es) 2007-02-16
EP0840895B1 (de) 2006-04-05

Similar Documents

Publication Publication Date Title
DE69636013D1 (de) Verfahren zum erlangen von rezeptor-freigabeligand (reland)-komplexen und testansätze
ATE99060T1 (de) Testverfahren und reagenzsatz dazu.
ES8400199A1 (es) Procedimiento para la produccion de dispositivos de analisis inmunologicos.
DE68901632D1 (de) Reaktionsgefaess zur durchfuehrung von aufeinanderfolgenden analytischen testen.
PH16420A (en) Despersed metal particles labelled assay
HU901367D0 (en) Intercellular adhesion molecule-2 and binding ligands thereof
ATE208900T1 (de) Verringerung des hook-effekts in immuntests mit teilchenförmigem trägermaterial
MX9604183A (es) Metodo de examen para identificar ligandos para proteinas objetivo.
ATE179799T1 (de) Vorrichtung zur analyse von haptenen und ihre verwendung
HUT65621A (en) Method for determination of concentration variants and compositions and test kits for use in such methods
KR910001379A (ko) 핵산 결정 방법
KR950701075A (ko) 생물학적 유체내 리간드의 양을 측정하는 방법 및 이를 수행하기 위한 키트(Method for determination of the amount of a ligand in a biololgical fluid and kit for carrying out such a method)
HK1021228A1 (en) In vitro method for determining the presence of hepatocellular carcinoma
AU3996693A (en) Process for the immunochemical determination of an analyte
EP0524502A3 (en) Immunoassay for free analyte
FI101830B1 (fi) Valonkestävä fysikaalinen kehite
DE69015056T2 (de) Trennung von Antikörpern gegen Metallchelate.
DE59409505D1 (de) Verfahren und Vorrichtung zur Gewinnung und zum Nachweis von immunologisch aktiven Substanzen aus der Gasphase
UA13688A1 (uk) Спосіб визhачеhhя тироксиhа у слиhі

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee